EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:233445 - (±)-suloctidil
| ChEBI ID | CHEBI:233445 |
| ChEBI Name | (±)-suloctidil |
| Stars | |
| ASCII Name | (+-)-suloctidil |
| Definition | A racemate comprising equimolar amounts of the erythro isomers, (1R,2S)-suloctidil and (1S,2R)-suloctidil. |
| Last Modified | 5 February 2025 |
| Submitter | Adnan |
| Formula | C20H35NOS |
| Net Charge | 0 |
| Average Mass | 337.573 |
| Monoisotopic Mass | 337.24394 |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | hepatotoxic agent A role played by a chemical compound exhibiting itself through the ability to induce damage to the liver in animals. antifungal agent An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce. calcium channel blocker One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. |
| Applications: | cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. platelet aggregation inhibitor A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. vasodilator agent A drug used to cause dilation of the blood vessels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (±)-suloctidil (CHEBI:233445) has part (1R,2S)-suloctidil (CHEBI:233451) |
| (±)-suloctidil (CHEBI:233445) has part (1S,2R)-suloctidil (CHEBI:233450) |
| (±)-suloctidil (CHEBI:233445) has role antifungal agent (CHEBI:35718) |
| (±)-suloctidil (CHEBI:233445) has role calcium channel blocker (CHEBI:38215) |
| (±)-suloctidil (CHEBI:233445) has role cardiovascular drug (CHEBI:35554) |
| (±)-suloctidil (CHEBI:233445) has role hepatotoxic agent (CHEBI:50908) |
| (±)-suloctidil (CHEBI:233445) has role platelet aggregation inhibitor (CHEBI:50427) |
| (±)-suloctidil (CHEBI:233445) has role vasodilator agent (CHEBI:35620) |
| (±)-suloctidil (CHEBI:233445) is a racemate (CHEBI:60911) |
| IUPAC Name |
|---|
| rac-(1R,2S)-2-(octylamino)-1-[4-(propan-2-ylsulfanyl)phenyl]propan-1-ol |
| INNs | Source |
|---|---|
| suloctidil | WHO MedNet |
| suloctidil | WHO MedNet |
| suloctidil | WHO MedNet |
| suloctidilum | WHO MedNet |
| Synonyms | Source |
|---|---|
| CP 556 S | ChEBI |
| CP 556S | ChEBI |
| CP-556S | ChEBI |
| CP556S | ChEBI |
| rac-suloctidil | ChEBI |
| erythro-p-(isopropylthio)-α-[1-(octylamino)ethyl]benzyl alcohol | ChEBI |
| Brand Names | Source |
|---|---|
| Bemperil | ChEBI |
| Cerebro | ChEBI |
| Circleton | ChEBI |
| Dulasi | ChEBI |
| Duloctil | ChEBI |
| Euvasal | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 2536 | DrugCentral |
| D05967 | KEGG DRUG |
| DB13340 | DrugBank |
| GB2123291 | Patent |
| HMDB0242578 | HMDB |
| LSM-1469 | LINCS |
| Suloctidil | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| CAS:54767-75-8 | ChEBI |
| Citations |
|---|